Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine
Clinical trial NCT04880785 · COMPLETED
Trial details
- NCT number
- NCT04880785
- Sponsor
- Fundacion SEIMC-GESIDA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2023-06-12
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.